Cas:61172-66-5 2-[(2-methylpropan-2-yl)oxycarbonylamino]pent-4-ynoic acid manufacturer & supplier

Chemical Name:2-[(2-methylpropan-2-yl)oxycarbonylamino]pent-4-ynoic acid

CAS.NO:61172-66-5

Synonyms:N-Boc-propargylglycine;2-Propargyl-L-glycine,N-BOC protected;N-Boc-2-propargyl glycine;D-2-Propargylglycine,N-BOC protected;Boc-L-propargylglycine

Molecular Formula:C₁₀H₁₅NO₄

Molecular Weight:213.23000

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:79.12000

Exact Mass:213.10000

LogP:1.19200

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like N-Boc-propargylglycine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Boc-L-propargylglycine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Boc-L-propargylglycine Use and application,2-Propargyl-L-glycine,N-BOC protected technical grade,usp/ep/jp grade.

Related News: Israel was a world leader in the vaccination rollout, with many seniors getting their shots in December, January and February as they were regarded as the most vulnerable sector of the population. 3-((3-(4-acetyl-2-allyl-3-hydroxyphenoxy)-2-hydroxypropyl)thio)propanoic acid manufacturers RELATED: With Takhzyro durability data, Takeda tries to fend off BioCryst’s hereditary angioedema challenger Orladeyo 1-(trichloromethyl)-3-(trichloromethyl-14C)benzene suppliers Novartis and GSK carried out a swap of its vaccine and cancer drugs back in 2015. GSK paid $5.25 billion to Novartis for its vaccine business, and Novartis sent $16 billion for GSK’s oncology programs. Tafinlar and Mekinist had already been granted FDA approval at the time of that deal, and as a part of that deal, Novartis agreed to divest its own BRAF and MEK inhibitors to avoid creating a monopoly. (η5:η5-C10H8)Mo2(CO)4(PMe3)2(CH3)2 vendor & factory.